CDA
CDA (cytidine deaminase, also known as CDD) is a pyrimidine salvage enzyme that hydrolytically deaminates cytidine and 2'-deoxycytidine to uridine and deoxyuridine. It helps maintain the cellular pyrimidine pool by scavenging both exogenous and endogenous nucleosides for UMP synthesis. Browse Assay Genie's current range of CDA research reagents below, or read on for the biology behind the target.
CDA is an enzyme of the pyrimidine salvage pathway. It scavenges exogenous and endogenous cytidine and 2'-deoxycytidine for UMP synthesis, catalysing the irreversible hydrolytic deamination of these nucleosides to uridine and deoxyuridine respectively. It is one of several deaminases responsible for maintaining the cellular pyrimidine pool.
The protein belongs to the cytidine and deoxycytidylate deaminase family and assembles as a homotetramer. The CDA gene encodes the enzyme in humans, and a mouse ortholog, Cda, is recorded. UniProt does not currently annotate a subcellular location for the protein, and the enzyme is classified under EC 3.5.4.5.
CDA is also of interest in pharmacology. Mutations in the gene are associated with decreased sensitivity to the cytosine nucleoside analogue cytosine arabinoside, which is used in the treatment of certain childhood leukaemias. The alias CDD is used for the same gene in some literature and databases, and researchers studying nucleoside metabolism or analogue response often examine CDA alongside other deaminases of the pyrimidine pool.
CDA scavenges cytidine and 2'-deoxycytidine for UMP synthesis, making it a focus for studies of how cells maintain their pyrimidine pool.
Mutations in CDA are associated with decreased sensitivity to cytosine arabinoside, so the enzyme is relevant to analogue metabolism research.
Because cytosine arabinoside is used in certain childhood leukaemias, CDA is studied in the context of treatment response in these diseases.
CDA forms a homotetramer and catalyses irreversible hydrolytic deamination, offering a model for the cytidine and deoxycytidylate deaminase family.
CDA catalyses the irreversible hydrolytic deamination of cytidine and deoxycytidine to uridine and deoxyuridine. In doing so it scavenges exogenous and endogenous cytidine and 2'-deoxycytidine for UMP synthesis and helps maintain the cellular pyrimidine pool.
Yes. The HGNC-approved symbol is CDA for cytidine deaminase, and CDD is a recorded alias. The enzyme is classified as EC 3.5.4.5 and belongs to the cytidine and deoxycytidylate deaminase family. It functions as a homotetramer.
Mutations in the CDA gene are associated with decreased sensitivity to cytosine arabinoside, a cytosine nucleoside analogue used in treating certain childhood leukaemias. A mouse ortholog, Cda, exists; check the datasheet of any product for its validated reactivity.
Other pyrimidine metabolism enzymes and nucleoside analogue pathway proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P32320; product specifications from Assay Genie datasheets.